Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

0.6840
+0.071911.75%
Post-market: 0.6700-0.0140-2.05%19:01 EST
Volume:100.37K
Turnover:64.28K
Market Cap:2.98M
PE:-0.03
High:0.6840
Open:0.6270
Low:0.6109
Close:0.6121
52wk High:12.14
52wk Low:0.5838
Shares:4.35M
Float Shares:3.77M
Volume Ratio:0.34
T/O Rate:2.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.6549
EPS(LYR):-22.6549
ROE:-1281.49%
ROA:-42.05%
PB:--
PE(LYR):-0.03

Loading ...

Scisparc Ltd. Held Special Shareholder Meeting

Reuters
·
Feb 05

SciSparc files $50M mixed securities shelf

TIPRANKS
·
Feb 04

Scisparc Ltd - to Offer up to $50 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Feb 04

SciSparc says Neurothera Labs granted U.S. patent for cannabinoid tech

TIPRANKS
·
Feb 02

Scisparc: Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance Such as Mrsa

THOMSON REUTERS
·
Feb 02

SciSparc Ltd.: NeuroThera Labs Granted U.S. Patent for Cannabinoid-Enhanced Antimicrobial Technology to Combat Antibiotic Resistance

Reuters
·
Feb 02

SciSparc completes acquisition of IP portfolio of patents, trademarks

TIPRANKS
·
Jan 26

SciSparc Acquires MUSE System IP Portfolio from Xylo Technologies

Reuters
·
Jan 26

Scisparc Successfully Completes Acquisition of Ip Portfolio, Advances Toward Immediate Commercialization

THOMSON REUTERS
·
Jan 26

SciSparc Moves Into Endoscopy With Strategic Patent Deal

Benzinga
·
Jan 14

BUZZ-SciSparc jumps as it buys acid reflux device patents, eyes global push

Reuters
·
Jan 13

SciSparc to Acquire Xylo’s MUSE Endoscopic Device Portfolio for 19.99% Equity Stake

Reuters
·
Jan 13

Scisparc Ltd - to Buy Muse System Patents From Xylo

THOMSON REUTERS
·
Jan 13

Scisparc Ltd - to Issue 19.99% Shares to Xylo Upon Closing

THOMSON REUTERS
·
Jan 13

Scisparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity

THOMSON REUTERS
·
Jan 13

Scisparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

THOMSON REUTERS
·
Jan 13

SciSparc Receives Nasdaq Non-Compliance Notice Over Minimum Equity Requirement

Reuters
·
Jan 13

SciSparc’s Neurothera Labs Granted Israeli Patent for Opioid-PEA Combination to Enhance Pain Relief and Reduce Side Effects

Reuters
·
Dec 30, 2025

Scisparc Ltd - Neurothera to Buy 55% Equity Interest in Target Company

THOMSON REUTERS
·
Dec 02, 2025

Scisparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company

THOMSON REUTERS
·
Dec 02, 2025